Speaker illustration

Mr Thilo Wilhelm Nitsche

University Medical Center of Schleswig-Holstein, Kiel (Germany)

Proline dehydrogenase (PRODH) as a metabolic target in cardiac health

Event: Heart Failure 2021

Topic: Gene Therapy, Cell Therapy

Session: ePoster session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb